Glipizide Tablet
Product Images NDC 0904-6637

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 0904-6637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipizide-structure.jpg (Glipizide Structure)

Glipizide-structure.jpg (Glipizide Structure)
Chemical structure diagram of the active ingredient Glipizide, showing its molecular arrangement including functional groups and ring structures.*
FDA Label Image

5mg Carton Label (F1793ea0 B041 708c Ff9e C711affdba6e 00)

5mg Carton Label (F1793ea0 B041 708c Ff9e C711affdba6e 00)
Label for Glipizide Tablets USP 5 mg, an oral prescription drug by Major Pharmaceuticals. The label shows the NDC 0904-6637-61 with package size of 100 tablets (10 x 10) in unit dose form. It includes storage instructions, dosage reference, and a barcode. The label notes the product is Rx only and intended for institutional use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.